0000919574-21-004286.txt : 20210625
0000919574-21-004286.hdr.sgml : 20210625
20210625154603
ACCESSION NUMBER: 0000919574-21-004286
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210625
FILED AS OF DATE: 20210625
DATE AS OF CHANGE: 20210625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BRADSHER NEAL C
CENTRAL INDEX KEY: 0001278388
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12830
FILM NUMBER: 211047567
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc.
CENTRAL INDEX KEY: 0000876343
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943127919
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: 5105213390
MAIL ADDRESS:
STREET 1: 2173 SALK AVENUE
STREET 2: SUITE 200
CITY: CARLSBAD
STATE: CA
ZIP: 92008
FORMER COMPANY:
FORMER CONFORMED NAME: BIOTIME INC
DATE OF NAME CHANGE: 19930328
4
1
ownership.xml
X0306
4
2021-06-25
0
0000876343
Lineage Cell Therapeutics, Inc.
LCTX
0001278388
BRADSHER NEAL C
C/O BROADWOOD CAPITAL INC.
142 WEST 57TH STREET, 11TH FLOOR
NEW YORK
NY
10019
1
0
1
0
Common Shares
2021-06-25
4
M
0
24720
2.20
A
87628
D
Common Shares
34005379
I
See Footnote
OPTION TO PURCHASE COMMON SHARES
2.20
2021-06-25
4
M
0
24720
0
D
2021-06-30
COMMON SHARES
24720
0
D
OPTION TO PURCHASE COMMON SHARES
0.8263
2030-07-01
COMMON SHARES
40000
40000
D
OPTION TO PURCHASE COMMON SHARES
1.03
2029-06-30
COMMON SHARES
40000
40000
D
OPTION TO PURCHASE COMMON SHARES
1.67
2023-06-30
COMMON SHARES
49440
49440
D
OPTION TO PURCHASE COMMON SHARES
2.55
2022-06-30
COMMON SHARES
24720
24720
D
These securities are directly owned by Broadwood Partners, L.P. ("Broadwood Partners") and may be deemed to be indirectly beneficially owned by: (i) Broadwood Capital, Inc. ("Broadwood Capital"), as General Partner of Broadwood Partners; and (ii) Neal C. Bradsher (the "Reporting Person"), as President of Broadwood Capital. Each of Broadwood Capital and the Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its or his pecuniary interest therein, and this report shall not be deemed an admission that Broadwood Capital or the Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
These options are currently exercisable.
/s/ Neal C. Bradsher
2021-06-25